特刊社论：慢性肾脏病及其并发症的病理生理学
Editorial for the Special Issue: Pathophysiology of Chronic Kidney Disease and Its Complications.
作者信息
Oe Yuji
机构信息
Division of Nephrology, Rheumatology and Endocrinology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
出版信息
Biomedicines. 2024 Feb 10;12(2):416. doi: 10.3390/biomedicines12020416.
Abstract
Chronic kidney disease (CKD) is a risk factor for end-stage kidney disease, requiring renal replacement therapy [...].
摘要
慢性肾脏病（CKD）是终末期肾病的一个危险因素，需要肾脏替代治疗[...]。
相似文献
1
Editorial for the Special Issue: Pathophysiology of Chronic Kidney Disease and Its Complications.特刊社论：慢性肾脏病及其并发症的病理生理学
Biomedicines. 2024 Feb 10;12(2):416. doi: 10.3390/biomedicines12020416.
3
Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.慢性肾脏病与经导管主动脉瓣置换术住院结局的相关性。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2050-2060. doi: 10.1016/j.jcin.2017.07.044.
4
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.预测危重症急性肾损伤患者需要肾脏替代治疗后发生严重长期慢性肾脏病的因素：ELVIS 随机对照试验的辅助研究。
Crit Care. 2022 Nov 29;26(1):367. doi: 10.1186/s13054-022-04233-4.
5
Fenestrated-branched endovascular aortic repair in patients with chronic kidney disease.慢性肾脏病患者的开窗分支型血管腔内修复术。
J Vasc Surg. 2020 Jul;72(1):66-72. doi: 10.1016/j.jvs.2019.09.035. Epub 2020 Feb 13.
6
Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease.慢性肾脏病儿童和青年患者按疾病严重程度进行患者报告的肾脏替代治疗规划讨论的时机。
Pediatr Nephrol. 2020 Oct;35(10):1925-1933. doi: 10.1007/s00467-020-04542-2. Epub 2020 May 3.
7
Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.转诊至肾脏病科的进展缓慢的老年慢性肾脏病患者肾替代治疗发生率较低：一项观察性研究。
BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.
8
In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study.慢性和终末期肾病患者经导管主动脉瓣置换术的院内转归：全国数据库研究。
BMC Cardiovasc Disord. 2024 Jan 3;24(1):21. doi: 10.1186/s12872-023-03684-z.
9
Chronic Kidney Disease After Acute Kidney Injury Requiring Continuous Renal Replacement Therapy and Its Impact on Long-Term Outcomes: A Multicenter Retrospective Cohort Study in Korea.连续性肾脏替代治疗后急性肾损伤导致的慢性肾脏病及其对长期结局的影响：韩国多中心回顾性队列研究。
Crit Care Med. 2017 Jan;45(1):47-57. doi: 10.1097/CCM.0000000000002012.
10
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.血清钾与 CKD 4-5 期老年人的死亡或肾脏替代治疗风险：8 年随访。
Am J Kidney Dis. 2023 Sep;82(3):257-266.e1. doi: 10.1053/j.ajkd.2023.03.008. Epub 2023 May 12.
引用本文的文献
1
Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine.解码肾脏病理生理学：精准医学中基于组学的方法
J Pers Med. 2024 Dec 19;14(12):1157. doi: 10.3390/jpm14121157.
本文引用的文献
1
Obesity-Related Kidney Disease: Current Understanding and Future Perspectives.肥胖相关肾病：当前认识与未来展望
Biomedicines. 2023 Sep 9;11(9):2498. doi: 10.3390/biomedicines11092498.
2
Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review.慢性肾脏病患者中风的流行病学及危险因素：一项叙述性综述
Biomedicines. 2023 Aug 27;11(9):2398. doi: 10.3390/biomedicines11092398.
3
Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease.2型心肾综合征男性患者与无确诊心血管疾病的慢性肾脏病患者循环免疫细胞亚群谱的差异。
Biomedicines. 2023 Mar 27;11(4):1029. doi: 10.3390/biomedicines11041029.
4
The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney.交感神经系统调节肾脏中钠葡萄糖协同转运蛋白1的表达。
Biomedicines. 2023 Mar 7;11(3):819. doi: 10.3390/biomedicines11030819.
5
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma.非转移性肾细胞癌中炎症和营养指标的预后价值比较
Biomedicines. 2023 Feb 12;11(2):533. doi: 10.3390/biomedicines11020533.
6
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1.抑制SGLT2和SGLT1对糖尿病肾脏保护的病理生理基础
Kidney Dial. 2022 Jun;2(2):349-368. doi: 10.3390/kidneydial2020032. Epub 2022 Jun 18.
7
New Insights into Molecular Mechanisms of Chronic Kidney Disease.慢性肾脏病分子机制的新见解
Biomedicines. 2022 Nov 8;10(11):2846. doi: 10.3390/biomedicines10112846.
8
Tissue Factor, Thrombosis, and Chronic Kidney Disease.组织因子、血栓形成与慢性肾脏病
Biomedicines. 2022 Oct 28;10(11):2737. doi: 10.3390/biomedicines10112737.
9
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
10
Stage II of Chronic Kidney Disease-A Tipping Point in Disease Progression?慢性肾脏病的II期——疾病进展的转折点？
Biomedicines. 2022 Jun 27;10(7):1522. doi: 10.3390/biomedicines10071522.
Zotero 插件